Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 183

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Mechanisms of hemolysis‐associated platelet activation

Open access
Helms, C.C., Marvel, M., Zhao, W., Stahle, M., Vest, R., Kato, G.J., Lee, J.S., Christ, G., Gladwin, M.T., Hantgan, R.R., Kim‐Shapiro, D.B.·2013·Journal of Thrombosis and Haemostasis

Abstract

Intravascular hemolysis occurs after blood transfusion, in hemolytic anemias, and in other conditions, and is associated with hypercoagulable states. Hemolysis has been shown to potently activate platelets in vitro and in vivo, and several mechanisms have been suggested to account for this, including: (i) direct activation by hemoglobin (Hb); (ii) increase in reactive oxygen species (ROS); (iii) scavenging of nitric oxide (NO) by released Hb; and (iv) release of intraerythrocytic ADP.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jth.12422

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 41

  1. Ataga, 2009, Hypercoagulability and thrombotic complications in hemolytic anemias, Haematologica, 94, 1481, 10.3324/haematol.2009.013672 · DOI · Paper page
  2. Marcus, 2001, Diabetes mellitus: a hypercoagulable state, J Diabetes Complicat, 15, 44, 10.1016/S1056-8727(00)00132-X · DOI · Paper page
  3. Gladwin, 2008, Hemolysis‐associated hypercoagulability in sickle cell disease: the plot (and blood) thickens!, Haematologica, 93, 1, 10.3324/haematol.12318 · DOI
  4. Karpman, 2006, Platelet activation in hemolytic uremic syndrome, Semin Thromb Hemost, 32, 128, 10.1055/s-2006-939769 · DOI
  5. Wun, 1998, Platelet activation in patients with sickle cell disease, Br J Haematol, 100, 741, 10.1046/j.1365-2141.1998.00627.x · DOI
  6. Kenny, 1980, Platelet hyperactivity in sickle‐cell disease: a consequence of hyposplenism, J Clin Pathol, 33, 622, 10.1136/jcp.33.7.622 · DOI · Paper page
  7. Iuliano, 1992, Free radical‐mediated platelet activation by hemoglobin released from red blood cells, Arch Biochem Biophys, 299, 220, 10.1016/0003-9861(92)90267-Z · DOI
  8. Born, 1976, Evidence for inhibition of platelet activation in blood by a drug effect on erythrocytes, Nature, 259, 233, 10.1038/259233a0 · doi:10.1038/259233a0
  9. Hu, 2010, The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model, Blood, 116, 1613, 10.1182/blood-2010-01-267112 · DOI
  10. Hellem, 1960, The adhesiveness of human blood platelets in vitro, Scand J Clin Lab Invest, 12, 1
  11. Gaarder, 1961, Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets, Nature, 11, 531, 10.1038/192531a0 · DOI · Paper page
  12. Bergquist, 1980, Haemostatic platelet plug formation in the isolated rabbit mesenteric preparation – an analysis of red blood cell participation, Thromb Haemost, 44, 6, 10.1055/s-0038-1650069 · doi:10.1055/s-0038-1650069
  13. Alkhamis, 1988, Red blood cell effect on platelet adhesion and aggregation in low‐stress shear flow: myth or fact?, ASAIO J, 34, 868
  14. Aursnes, 1992, Low dose infusion of adenosine diphosphate prolongs bleeding time in rats and rabbits, Thromb Res, 68, 67, 10.1016/0049-3848(92)90128-W · doi:10.1016/0049-3848(92)90128-w
  15. Doni, 1975, ADP‐induced platelet aggregatioin in vivo after exclusion of different circulatory districts, Experientia, 31, 1224, 10.1007/BF02326805 · doi:10.1007/bf02326805
  16. Silvain, 2010, Impact of red blood cell transfusion on platelet activation and aggregation in healthy volunteers: results of the transfusion study, Eur Heart J, 31, 2816, 10.1093/eurheartj/ehq209 · DOI
  17. Foster, 2001, Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs, J Clin Invest, 107, 1591, 10.1172/JCI12242 · DOI · Paper page
  18. Meadows, 2007, Clinical aspects of platelet inhibitors and thrombus formation, Circ Res, 100, 1261, 10.1161/01.RES.0000264509.36234.51 · DOI · Paper page
  19. Bogle, 1991, Bradykinin and ATP stimulate L‐arginine uptake and nitric oxide release in vascular endothelial cells, Biochem Biophys Res Commun, 180, 926, 10.1016/S0006-291X(05)81154-4 · DOI · Paper page
  20. Silva, 2006, Extracellular ATP stimulates NO production in rat thick ascending limb, Hypertension, 47, 563, 10.1161/01.HYP.0000197954.93874.ef · doi:10.1161/01.hyp.0000197954.93874.ef
  21. Ishida, 2013, Mechanisms underlying reduced P2Y1‐receptor‐mediated relaxation in superior mesenteric arteries from long‐term streptozotocin‐induced diabetic rats, Acta Physiol, 207, 130, 10.1111/j.1748-1716.2012.02469.x · DOI
  22. Wollny, 1997, Prolongation of bleeding time by acute hemolysis in rats: a role for nitric oxide, Am J Physiol Heart Circul Physiol, 272, H2875, 10.1152/ajpheart.1997.272.6.H2875 · DOI
  23. Azuma, 1986, Endothelium‐dependent inhibition of platelet aggregation, Br J Pharmacol, 88, 411, 10.1111/j.1476-5381.1986.tb10218.x · DOI · Paper page
  24. Schafer, 2004, Rapid regulation of platelet activation in vivo by nitric oxide, Circulation, 109, 1819, 10.1161/01.CIR.0000126837.88743.DD · DOI
  25. Huang, 2007, Nitric oxide red blood cell membrane permeability at high and low oxygen tension, Nitric Oxide Biol Chem, 16, 209, 10.1016/j.niox.2006.11.002 · DOI · Paper page
  26. Doherty, 1998, Rate of reaction with nitric oxide determines the hypertensive effect of cell‐free hemoglobin, Nat Biotechnol, 16, 672, 10.1038/nbt0798-672 · DOI · Paper page
  27. Butler, 1998, Diffusion of nitric oxide and scavenging by blood in the vasculature, BBA Gen Subjects, 1425, 168, 10.1016/S0304-4165(98)00065-8 · DOI · Paper page
  28. Liu, 2002, Nitric oxide uptake by erythrocytes is primarily limited by extracellular diffusion not membrane resistance, J Biol Chem, 277, 26194, 10.1074/jbc.M201939200 · DOI
  29. Azarov, 2005, Nitric oxide scavenging by red blood cells as a function of hematocrit and oxygenation, J Biol Chem, 280, 39024, 10.1074/jbc.M509045200 · DOI · Paper page
  30. Azarov, 2011, Mechanisms of slower nitric oxide uptake by red blood cells and other hemoglobin‐containing vesicles, J Biol Chem, 286, 33567, 10.1074/jbc.M111.228650 · DOI
  31. Vaughn, 2000, Erythrocytes possess an intrinsic barrier to nitric oxide consumption, J Biol Chem, 275, 2342, 10.1074/jbc.275.4.2342 · DOI · Paper page
  32. Gladwin, 2003, Divergent nitric oxide bioavailability in men and women with sickle cell disease, Circulation, 107, 271, 10.1161/01.CIR.0000044943.12533.A8 · DOI · Paper page
  33. Kato, 2006, Lactate dehydrogenase as a biomarker of hemolysis‐associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease, Blood, 107, 2279, 10.1182/blood-2005-06-2373 · DOI · Paper page
  34. Reimers, 1984, Potentiation by red‐blood‐cells of shear‐induced platelet‐aggregation – relative importance of chemical and physical‐mechanisms, Blood, 64, 1200, 10.1182/blood.V64.6.1200.1200 · doi:10.1182/blood.v64.6.1200.1200
  35. Saniabadi, 1983, Platelet‐aggregation studies in whole human‐blood, Thromb Res, 30, 625, 10.1016/0049-3848(83)90271-2 · doi:10.1016/0049-3848(83)90271-2
  36. Kehrel, 2013, State of the art in platelet function testing, Transfus Med Hemother, 40, 73, 10.1159/000350469 · DOI
  37. Rother, 2005, The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin, JAMA, 293, 1653, 10.1001/jama.293.13.1653 · DOI · Paper page
  38. Hamasaki, 1974, The binding of phosphorylated red blood cell metabolites to human hemoglobin A, J Biol Chem, 249, 7896, 10.1016/S0021-9258(19)42050-4 · DOI
  39. Morris, 2005, Dysregulated arginine metabolism, hemolysis‐associated pulmonary hypertension, and mortality in sickle cell disease, JAMA, 294, 81, 10.1001/jama.294.1.81 · DOI · Paper page
  40. Barr, 2013, Red blood cells mediate the onset of thrombosis in the ferric chloride murine model, Blood, 121, 3733, 10.1182/blood-2012-11-468983 · DOI · Paper page
  41. Pratico, 1999, Iron‐dependent human platelet activation and hydroxyl radical formation – involvement of protein kinase C, Circulation, 99, 3118, 10.1161/01.CIR.99.24.3118 · DOI

Cited by

See all 183

Metadata

Authors
Helms, C. C., Marvel, M., Zhao, W., Stahle, M., Vest, R., Kato, G. J., Lee, J. S., Christ, G., Gladwin, M. T., Hantgan, R. R., & Kim‐Shapiro, D. B.
Venue
Journal of Thrombosis and Haemostasis
Publisher
Elsevier BV
Published
2013-12
Volume
11
Issue
12
Pages
2148-2154
ISSN
1538-7836 (ISSN-L)
OpenAlex
W2030378408
Cited by
183
References
5
FWCI
7.47
Type
journal article
Language
en
Open access
bronze
Licence
Funders
  • NIH (HL058091, HL098032)
  • Harbert Family Distinguished Chair funds
  • NIH Intramural Program 1 ZIA (HL006014)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.